ESG

With multiple Best in KLAS awards, Bluesight cements its leadership in patient safety and data security. Here's why hospitals trust their solutions.

A world-first trial for personalized mRNA vaccines offers new hope for children with aggressive brain tumors, a mission born from a father's own fight.

The 90-year-old insurer goes live with Equisoft's SaaS platform, tackling industry-wide tech debt to boost agent efficiency and speed product launches.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

Caribou Biosciences unveils new data showing its 'off-the-shelf' CAR-T cells achieve deep, lasting responses in lymphoma and myeloma clinical trials.

Acarix's CADScor®System gains stringent EU MDR certification, a move poised to reshape cardiac diagnostics and fuel the company's expansion in the U.S.

As Aspen Aerogels prepares its Q4 results, investors weigh a challenging 2025 against a booming aerogel market and future EV growth prospects.

For the second straight year, Collette Health is #1 in virtual care. Discover how its integrated platform is redefining hospital efficiency and patient safety.

With crucial data on its novel oral inflammation inhibitor looming, NodThera brings in seasoned leader Geoff McDonough to navigate the path to Phase 3.

With a 90% clinical trial failure rate, BullFrog AI is launching a new tool to help drugmakers make smarter, risk-balanced R&D decisions.

Superior Health's acquisition of Pulse Home Health, backed by private equity, signals a major shift in Louisiana's booming home health and hospice market.

Dragonfly Energy's new power pack won two major sustainability awards. The tech cuts truck idling by 70%, saving fleets fuel and slashing emissions.

The Bozeman tech firm saw record growth as the energy sector embraces its advanced LiDAR for methane detection and navigating complex global regulations.

VENU closes a $13M deal for its first indoor venue, bringing an innovative fractional ownership "FireSuite" concept to the Denver area.

Automotive seating giant Adient boosts its 2026 forecast, banking on strong North American production and operational gains, despite a reported net loss.

A landmark survey reveals a massive capital rotation as 96% of institutions chase AI and 81% move to private markets to navigate a fragmenting world.

Organon expands its Women's Health Accelerator to META, aiming to close health gaps and unlock a potential £1 trillion economic boost through digital innovation.

Tencent and HeritageSG launch an AI-powered robot guide, turning museum visits into interactive adventures and setting a new standard for heritage learning.

A new AI-driven approach to cancer therapy promises to breach the blood-brain barrier, offering hope for treating aggressive tumors where others have failed.

The global certification giant is betting big on ASEAN's dynamic market, moving from a license model to full control to tap into rising regulatory demands.